10 Stocks to Buy According to Neil Shahrestani’s Ikarian Capital
In this article, we will take a look at the 10 stocks to buy according to Neil Shahrestani's Ikarian Capital.
Milestone Pharmaceuticals Inc. (MIST)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 2,583,821 | $16,588 | 0.26% | |
| 2. | RA Capital Management Peter Kolchinsky | 2,246,503 | $14,423 | 0.31% | |
| 3. | Ikarian Capital Neil Shahrestani | 1,928,752 | $12,383 | +11% | 1.62% |
| 4. | Millennium Management Israel Englander | 1,288,923 | $8,275 | +31% | 0% |
| 5. | Pura Vida Investments Efrem Kamen | 987,411 | $6,339 | +7% | 0.21% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.87 | 5,870 | Large Shareholder | 4,315,102 | 2020-03-19 | Filing | |
| $10.36 | 2,705 | Large Shareholder | 4,309,232 | 2020-03-18 | Filing | |
| $18.95 | 78,263 | Large Shareholder | 4,306,527 | 2020-03-02 | Filing | |
| $16.25 | 270,000 | Large Shareholder | 4,228,264 | 2020-01-13 | Filing | |
| $15.50 | 21,438 | Large Shareholder | 3,958,264 | 2019-12-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.32 | 500,000 | Large Shareholder | 2,254,920 | 2020-07-29 | Filing | |
| $8.10 | 19,863 | Large Shareholder | 2,754,920 | 2020-07-28 | Filing | |
| $16.00 | 240,000 | Large Shareholder, Other | 2,434,470 | 2019-11-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 4,315,102 | $27,703 | 0.57% | |
| 2. | 3,848 | $24,704 | 0% | |
| 3. | 2,530,003 | $16,243 | 0.68% | |
| 4. | 2,238,861 | $14,373 | 0.73% | |
| 5. | 818,640 | $5,256 | 0% |
News See All
Is Milestone Pharmaceuticals (MIST) A Good Stock To Buy Now?
In this article we will take a look at whether hedge funds think Milestone Pharmaceuticals Inc. (NASDAQ:MIST) is a good investment right now.
Milestone Pharmaceuticals Inc. (MIST): Are Hedge Funds Right About This Stock?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Should You Avoid Milestone Pharmaceuticals Inc. (MIST)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Billionaire Hedge Funds
